Genzyme Corp -Cholestagel - Ownership and Business Overview

Medical ProductsCompany

Genzyme Corp -Cholestagel Ownership

Who owns Genzyme Corp -Cholestagel?

Genzyme Corp -Cholestagel is owned by Bausch Health Companies. It was acquired on February 10, 2011.

Genzyme Corp -Cholestagel Business Overview

Where is Genzyme Corp -Cholestagel headquartered?

Genzyme Corp -Cholestagel is headquartered in Ontario.

What sector is Genzyme Corp -Cholestagel in?

Genzyme Corp -Cholestagel is a medical products company.

Medical Products M&A Summary in 2011

Out of 60 sectors in the Mergr database, medical products ranked 7 in number of deals in 2011. The largest medical products acquisition in 2011 was Synthes - which was acquired by Johnson & Johnson for $19.3B.

Join Mergr to view all 188 acquisitions of medical products companies in 2011, including 40 acquisitions by private equity firms, and 148 by strategics.

Genzyme Corp -Cholestagel(R)

Ontario
Canada,

Genzyme Corp -Cholestagel(R) Colesevelam is a bile acid sequestrant administered orally. Cholestagel(R) is contraindicated in patients who are hypersensitive to this drug or to any ingredient in the formulation or component of the container. Cholestagel(R) is contraindicated in patients with bowel or biliary obstruction. Cholestagel(R) is contraindicated in patients with serum triglyceride (TG) > 500 mg/dL and in patients with a history of hypertiglyceridemia-induced pancreatitis.


 Subscribe to unlock this and 206,758
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.